Clinical trial Recruiting at 1 site Observational

Monitoring cardiovascular rehabilitation outcomes in Switzerland

Official title: Swiss Secondary Prevention and Rehabilitation Registry: SwissPR

Run by University Hospital, Basel, Switzerland · NCT05500859 · Data updated 2026-11-12

This study looks at how a 12-week heart rehabilitation program in Switzerland affects patients' heart health and helps identify those at higher risk for heart problems.

More Cardiovascular Diseases (CVD) trials

Quick facts

Study typeObservational
SexAll
Enrollment4000 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations1 site (Basel)
StatusRecruiting
StartedDecember 20, 2019
Main results expectedDecember 2035
Study endsDecember 2035
Registry record updatedJuly 22, 2025
Trial IDNCT05500859 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals of all age groups who are participating in an ambulatory cardiac rehabilitation program and can provide informed consent.

Probably not a fit

Patients who are unable to follow an ambulatory cardiac rehabilitation program for more than three weeks or who cannot provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The SwissPR study is a longitudinal observational cohort study that aims to monitor patient characteristics and benchmark quality measures for individuals participating in a 12-week ambulatory cardiac rehabilitation program at the University Hospital Basel. It includes both retrospective and prospective data collection to assess the impact of the rehabilitation program on cardiovascular health outcomes. The study seeks to identify patients at higher cardiovascular risk and understand the factors influencing secondary prevention behaviors. By creating a comprehensive registry, the study addresses the lack of data on the Swiss population's experiences during and after cardiac rehabilitation.

Why it matters

Potential benefit: If successful, this study could improve the quality of cardiac rehabilitation programs and enhance patient outcomes for those with cardiovascular diseases.

How similar studies have gone: Other studies have shown success in monitoring rehabilitation outcomes, but this specific registry approach is novel for the Swiss population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participation in an ambulatory CR program (all age groups)
* Written informed consent

Exclusion Criteria:

* Inability to follow an ambulatory CR program more than 3 weeks
* Not willing to give informed consent
* Inability to understand the informed consent due to language comprehension
* Lack of discernment

Where it's running

  • University Hospital Basel, Division of Outpatient Cardiology
    Basel, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Otmar Pfister, Prof. Dr. med. — Outpatient Cardiology, University Hospital Basel
  • Study coordinator: Otmar Pfister, Prof. Dr. med.
  • Email: otmar.pfister@usb.ch
  • Phone: +41 61 328 7482

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.